Name: COGT Balance Sheet - Cogent Biosciences Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

COGT - Cogent Biosciences, Inc.

USD | NASDAQ | Healthcare

COGT Balance Sheet - Cogent Biosciences Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Cash And Short Term Investments
Cash And Equivalents	312.0	98.2	53.2	139.9	219.7	242.2	37.4	55.7	28.3	-
Restricted Cash	-	-	0.0	1.3	-	-	-	-	0.1	-
Short Term Investments	-	-	-	-	-	-	-	22.9	12.7	-
Cash And Short Term Investments	312.0	98.2	53.2	139.9	219.7	242.2	37.4	78.6	41.0	-
Receivables
Accounts Receivable	-	-	-	-	-	-	2.0	1.7	0.8	-
Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	9.6	9.4	5.1	4.4
Non-Current Assets
Property, Plant & Equipment Gross	14.1	12.6	12.0	9.2	2.3	0.5	6.5	6.7	6.3	-
Accumulated Depreciation	8.7	6.1
Current Liabilities
Accounts Payable	9.5	12.0	10.7	5.8	3.5	0.7	3.2	1.5	1.3	-
Short Term Debt	-	-	-	-
Non-Current Liabilities
Long Term Debt	222.9	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	14.4	15.9	17.5
Common Equity
Common Stock	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	-
Additional Paid In Capital	-	-	-	-
Supplementary Data
Total Debt	222.9	-	-	-	-	-	-	-	-	-
Net debt	(89.1)	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q4 FY 16
Cash And Short Term Investments
Cash And Equivalents	241.2	312.0	125.3	127.6	126.0	98.2	97.0	88.2	215.8	53.2	86.8	214.3	160.7	139.9	140.6

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	11.4	9.6	6.4	7.2	7.2	9.4	6.0	6.8	6.2	5.1	6.9	5.1	4.8	4.4	6.1	3.9	3.7	2.9
Other Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	877.8	910.4	397.2	245.0	252.9	296.5	341.5	370.0	441.9	270.8	286.0	334.5	226.3	265.0	296.4	330.7

Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Property,Plant & Equipment Net	5.3	5.5	5.3	5.9	6.5	6.5	7.0	7.4	7.8	8.3	8.6	9.1	9.0	7.8	6.5	3.6	2.1
Long Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Right Of Use Assets	17.5	18.1	18.6	19.1	19.6	20.1	20.6	21.1	21.5	22.0	22.2	22.5	23.1	23.3	23.8	26.9
Deferred Tax Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Assets	1.9	3.3	4.5	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.9	4.8	4.8	4.7	4.8	4.9	5.6
Total Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	903.0	937.6	425.9	274.8	283.8	327.9	384.0	429.9	476.1	313.4	355.4	392.4	263.2	300.8	331.6	366.1	206.9

Current Liabilities
Accounts Payable	13.7	9.5	16.0	16.6	14.2	12.0	15.1	9.0	15.6	10.7	9.9	7.2	4.2	5.8	4.1	3.5	4.0	3.5	4.3	2.0	0.3	-	0.6	0.6	0.6	3.2	1.6	1.7	1.8	1.5	0.8	1.7	3.1	1.3	-
Short Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Current	1.4	1.5	1.7	1.7	1.6	1.6	1.5	1.5	1.4	1.4	1.3	1.2	0.9	1.4	2.0	9.1
Accrued Expenses	6.2	15.7	10.5	8.1	3.7	12.3	7.7	5.7	2.4	9.9	5.9	4.8	2.2	6.1	4.1	3.2	1.5	3.4
Other Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	58.0	64.0	62.2	58.4	49.3	55.7	53.0	40.0	36.7	38.2	34.7	25.8	21.1	26.8	23.6

Non-Current Liabilities
Long Term Debt	223.2	-	44.3	43.9	-	0.0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	14.1	14.4	14.6	15.1	15.5	15.9	16.3	16.7	17.1	17.5	17.8	18.2	18.5	18.2	18.1	19.0
Deferred Revenue Non-Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	0.1	0.0	2.4	2.4	0.0	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	295.3	301.2	123.5	119.8	64.8	71.6	69.4	56.7	53.8	55.6	52.5	43.9	39.6	45.1	41.6	46.7

Common Equity
Common Stock	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	-	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-
Additional Paid In Capital	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	(1,285.8)	(1,188.4)	(1,085.9)	(1,005.0)	(931.5)	(859.5)	(791.6)	(720.9)	(662.0)	(603.6)	(549.3)	(493.9)	(449.8)	(411.2)	(371.6)	(336.5)	(301.6)
Accumulated Other Comprehensive Income	(0.4)	0.4	0.2	0.0	0.2	0.4	0.9	(0.2)	(0.0)	0.2	(0.2)	(0.1)	0.0	(0.1)	(0.2)	-
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	607.7	636.4	302.5	155.0	219.0	256.3	314.7	373.2	422.3	257.8	302.9	348.4	223.6	255.7	289.9	319.4	187.9
Total Equity	607.7	636.4	302.5	155.0	219.0	256.3	314.7	373.2	422.3	257.8	302.9	348.4	223.6	255.7	289.9	319.4	187.9	214.2